2Parashar UD,Hummelman EG,Breasee J S,et al.Global illness and deaths caused by rotavirus disease in children.Emerg Infect Dis,2003,9(5):565-572.
3Conner ME,Graham DY,Estes MK.Determination of the duration of a primary immune response and the ID50 of ALA rabbit rotavirus in rabbits.Arch Virol,1997,142:2281-2294.
4Anonymous.Withdrawal of rotavrus vaccine recommendation MMWR Morb Mortal Wkly Rep,1999,48(43):1007.
5Zhou W,Pool V,Iskander J K,et al.Surveillance for safety after immunization:vaccine adverse event reporting system-United States 1991-2001.Pediatrics,2002,110(6):e67.
6Murphy BR,Morens DM,Simonsen L,et al.Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions.J Infect Dis,2003,187(8):1301-1308.
7Bernstein DI,Sack DA,Reisinger K,et al.Second-year follow-up evaluation of live,attenuated human rotavirus vaccine 89-12 in healthy infants.J Infect Dis,2002,186(10):1487-1489.
8Ruiz-Palacios GM,Perez-Schael I,Velazyuez FR,et al.Safety and Efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.N Engl JV Med,2006,354(1):11-22.
9Vesikari T,Matson Do,Dennehy P,et al.Safety and efficacy of a pentavalent human-bovine(WC3) reassortant rotavirus vaccine.N Engl J Med,2006,354(1):23-33.
10Midthum K,hoshino Y,Kapikian AZ,et al.Single gene substitution rotavirus reassortants containing the major neutralization protein (VP7) of human rotavirus serotype 4.J Clin Microbiol,1986,24(5):822-826.
